The sunpharma has breaked its 7 years high and may test its ATH which is at 1200. Fundamentals are also good. The promoters has unpledged 1.51% of shares. The volume is also good and the daily delivery is 67% while the 6 months average is only 54.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
